Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion type Assertion NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_head.
- NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion description "[Taken together, the results indicate that DNAJB8 is expressed and has role in CRC CSC/CIC and that DNAJB8 is a novel target of CRC CSC/CIC-targeting immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_provenance.
- NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion evidence source_evidence_literature NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_provenance.
- NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion SIO_000772 24450541 NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_provenance.
- NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion wasDerivedFrom befree-20150227 NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_provenance.
- NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_assertion wasGeneratedBy ECO_0000203 NP868578.RAQTheb50NlEnktISFr5kTNiSuLvDWQlqcqcM2yBDf_1E130_provenance.